BP
BioMarin Pharmaceutical Inc.
BMRN· Health Care· BiotechnologyS&P 400
Close · 10/09/2026
65.51
1D
+1.71%52-week range
49.26 – 70.98
Volume
22,02,700.00
Price history
BMRN
11/08/2026 to 10/09/2026
O 64.41 H 65.59 L 63.57
1W-2.18%
1M-5.81%
3M+16.63%
6M+8.60%
1Y+17.63%
3Y-27.80%
5Y-22.26%
MAX-21.02%
Fundamentals
as of 10/09/2026- Market cap
- $12.68B
- Shares out
- 193.57M
- P/E (trailing)
- 173.78
- P/E (forward)
- 10.18
- EPS (trailing)
- 0.38
- Beta
- 0.24
- Profit margin
- 2.14%
- P/B
- 2.01
- Return on equity
- 1.15%
SEC financial statements
52 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- BMRN
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
2 filers · 0 on watchlist · 2 buys · 1 sell · ?: 3
- 06/03/2023Daniel GoldmanSellBioMarin Pharmaceutical Inc.$1,001–$15,000
- 18/01/2018Alan S. LowenthalBuyBioMarin Pharmaceutical Inc. (BMRN) FILINg STATuS: New SuBHOLDINg OF: Neuberger Berman - Traditional IRA$1,001–$15,000
- 17/01/2018Alan S. LowenthalBuyBioMarin Pharmaceutical Inc. (BMRN) FILINg STATuS: New SuBHOLDINg OF: Neuberger Berman - Traditional IRA$1,001–$15,000